Current status of atopic dermatitis in Japan
Asia Pacific Allergy
;
(4): 64-72, 2011.
Article
in English
| WPRIM
| ID: wpr-749868
ABSTRACT
Atopic dermatitis (AD) is a common, chronic or chronically relapsing, severely pruritic, eczematous skin disease. AD is the second most frequently observed skin disease in dermatology clinics in Japan. Prevalence of childhood AD is 12-13% in mainland Japan; however, it is only half that (about 6%) in children from Ishigaki Island, Okinawa. Topical steroids and tacrolimus are the mainstay of treatment. However, the adverse effects and emotional fear of long-term use of topical steroids have induced a "topical steroid phobia" in patients throughout the world. Undertreatment can exacerbate facial/periocular lesions and lead to the development of atopic cataract and retinal detachment due to repeated scratching/rubbing/patting. Overcoming topical steroid phobia is a key issue for the successful treatment of AD through education, understanding and cooperation of patients and their guardians.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Phobic Disorders
/
Skin Diseases
/
Steroids
/
Cataract
/
Retinal Detachment
/
Prevalence
/
Tacrolimus
/
Skin Diseases, Eczematous
/
Dermatitis, Atopic
/
Dermatology
Type of study:
Prevalence study
Limits:
Child
/
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Asia Pacific Allergy
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS